Correlation Between Immix Biopharma and Pyxis Oncology
Can any of the company-specific risk be diversified away by investing in both Immix Biopharma and Pyxis Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immix Biopharma and Pyxis Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immix Biopharma and Pyxis Oncology, you can compare the effects of market volatilities on Immix Biopharma and Pyxis Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immix Biopharma with a short position of Pyxis Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immix Biopharma and Pyxis Oncology.
Diversification Opportunities for Immix Biopharma and Pyxis Oncology
0.16 | Correlation Coefficient |
Average diversification
The 3 months correlation between Immix and Pyxis is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Immix Biopharma and Pyxis Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pyxis Oncology and Immix Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immix Biopharma are associated (or correlated) with Pyxis Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pyxis Oncology has no effect on the direction of Immix Biopharma i.e., Immix Biopharma and Pyxis Oncology go up and down completely randomly.
Pair Corralation between Immix Biopharma and Pyxis Oncology
Given the investment horizon of 90 days Immix Biopharma is expected to generate 0.43 times more return on investment than Pyxis Oncology. However, Immix Biopharma is 2.32 times less risky than Pyxis Oncology. It trades about 0.05 of its potential returns per unit of risk. Pyxis Oncology is currently generating about -0.15 per unit of risk. If you would invest 163.00 in Immix Biopharma on August 24, 2024 and sell it today you would earn a total of 5.00 from holding Immix Biopharma or generate 3.07% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Immix Biopharma vs. Pyxis Oncology
Performance |
| Timeline |
| Immix Biopharma |
| Pyxis Oncology |
Immix Biopharma and Pyxis Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Immix Biopharma and Pyxis Oncology
The main advantage of trading using opposite Immix Biopharma and Pyxis Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immix Biopharma position performs unexpectedly, Pyxis Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pyxis Oncology will offset losses from the drop in Pyxis Oncology's long position.| Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
| Pyxis Oncology vs. Lyra Therapeutics | Pyxis Oncology vs. Hookipa Pharma | Pyxis Oncology vs. Cingulate Warrants | Pyxis Oncology vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |